PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment.

The lawsuit says “nearly everyone” at the county jail facilities are denied direct-acting antiviral drugs as part of practices by Wellpath, a privately-contracted health care provider.

Prisoners' Legal Services said the sheriff’s office is denying treatment to “nearly everyone” with hepatitis C in Essex ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

The likelihood of HCV clearance was increased by participation in Ryan White services among patients with HIV coinfection.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

The closure of the Centers for Disease Control and Prevention (CDC)’s Division of Viral Hepatitis in the wake of the administration’s restructuring of the Department of Health and Human Services ...

All the scientists were fired from the only STI lab in the US that tested how well antibiotics were working against drug-resistant gonorrhea strains.